Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-25-005702
Filing Date
2025-04-28
Accepted
2025-04-28 17:00:56
Documents
22
Period of Report
2025-06-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A iova-20250610xdef14a.htm   iXBRL DEF 14A 1903428
2 GRAPHIC iova-20250610xdef14a_a002.jpg GRAPHIC 15019
3 GRAPHIC iova-20250610xdef14a_a008.jpg GRAPHIC 46036
4 GRAPHIC iova-20250610xdef14a_a019.jpg GRAPHIC 53917
5 GRAPHIC iova-20250610xdef14a_a020.jpg GRAPHIC 49495
6 GRAPHIC iova-20250610xdef14a_bg001.jpg GRAPHIC 132097
7 GRAPHIC iova-20250610xdef14a_bg002.jpg GRAPHIC 110604
  Complete submission text file 0001558370-25-005702.txt   4125936

Data Files

Seq Description Document Type Size
8 EX-101.SCH iova-20250610.xsd EX-101.SCH 5440
9 EX-101.DEF iova-20250610_def.xml EX-101.DEF 5953
10 EX-101.LAB iova-20250610_lab.xml EX-101.LAB 11561
11 EX-101.PRE iova-20250610_pre.xml EX-101.PRE 7531
24 EXTRACTED XBRL INSTANCE DOCUMENT iova-20250610xdef14a_htm.xml XML 368350
Mailing Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

EIN.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36860 | Film No.: 25881373
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)